MAY 11, 2020 Intelligence: Late-Breaking Lab News

Clinical laboratories in¬†other countries have¬†similar challenges in¬†responding to the COVID-19 pandemic. In the United¬†Kingdom, the Independent¬†reported last week that ‚ÄúWidespread¬†testing for coronavirus¬†has been suspended among¬†staff and patients at hospitals¬†and GP practices serving 3.5¬†million people because of a¬†shortage of vital chemicals.‚Ä̬†According to Independent¬†reporter Shaun Lintern, medical¬†laboratories serving South¬†London are unable to access¬†adequate supplies of reagents¬†and other clinical lab supplies¬†required to meet the demand¬†for COVID-19 testing.


Just as in the United States,¬†the news media in the United¬†Kingdom is publishing stories¬†daily about the gap between¬†the number of COVID-19¬†tests needed and the ability¬†of medical laboratories in that¬†country to deliver enough¬†COVID-19 tests. The Independent¬†wrote that ‚Äúthe South¬†West London Pathology¬†Partnership provides testing¬†for St. George‚Äôs Hospital,¬†Kingston Hospital Foundation¬†Trust, Croydon Health¬†Services Trust, and Epsom¬†and St. Helier Hospitals¬†Trust. It also serves more than¬†200 GPs across the capital.‚ÄĚ


In Australia, the COVID-19¬†pandemic triggered a substantial¬†decline in routine test volumes¬†at the nation‚Äôs medical¬†laboratories. To cut their costs¬†during the outbreak, several lab¬†companies are asking general¬†practice (GP) clinics to accept a¬†50% reduction in the rent they¬†pay to maintain blood draw¬†stations in the clinics. However,¬†loss of this revenue is hurting¬†GP practices. The Guardian¬†noted that David Dahm, an¬†accounting consultant to GPs¬†in Adelaide, described these GP¬†clinics as ‚Äúgazing into a ‚Äėfunding¬†black hole,‚Äô‚ÄĚ with Dahm adding¬†that ‚ÄúGPs live off [the government‚Äôs¬†practice incentives¬†program] and pathology rent¬†[for drawing stations in their¬†practices].‚ÄĚ


‚Äʬ†Personal Genome Diagnostics¬†of Baltimore appointed¬†Megan Bailey as its new CEO.¬†Bailey has held executive positions¬†at Roche Diagnostics¬†and Ventana Medical Systems.

‚ÄĘ Personalis of San Jose,¬†Calif. announced that Stephen¬†Moore is now its General¬†Counsel. Moore formerly¬†served at Pacific Biosciences,¬†Navigenics, Affymetrix, and¬†Adobe Systems.

‚ÄĘ Ingo Chakravarty is the new¬†President and CEO of Mesa¬†Biotech of San Diego. He previously¬†held positions at Navican,¬†GenMark Diagnostics,¬†Gen-Probe, Roche Diagnostics,¬†and Ventana Medical¬†Systems.



Have you caught the latest¬†e-briefings from DARK Daily?¬†If so, then you‚Äôd know …

…how the Innovative Genomics¬†Institute (IGI) at the University¬†of California, Berkeley used¬†its research equipment to make¬†a COVID-19 diagnostic testing¬†laboratory operational in just a¬†few weeks. It can do 3,000 tests¬†daily with results in four hours.

You can get the free DARK Daily e-briefings by signing up

That’s all the insider intelligence for this report. Look for the next briefing on Monday, June 1, 2020.



Leave a Reply


You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

Privacy Policy: We will never share your personal information.